Display Settings:

Format

Send to:

Choose Destination
Anesth Analg. 2011 Oct;113(4):858-61. doi: 10.1213/ANE.0b013e318228a001. Epub 2011 Aug 4.

Perioperative exacerbation of valproic acid-associated hyperammonemia: a clinical and genetic analysis.

Author information

  • 1Department of Anesthesiology, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, H187 500 University Dr., PO Box 850, Hershey, PA 17033-0850, USA. dbezinover@hmc.psu.edu

Abstract

We present a case of significant deterioration of chronic hyperammonemia after general anesthesia for neurosurgery despite aggressive treatment. Preoperative evaluation demonstrated that hyperammonemia was most likely related to valproic acid treatment. Genomic analysis revealed that the patient was heterozygotic for a missense polymorphism in the carbamoyl phosphate synthase 1 gene (4217C>A, rs1047891). This mutation was previously suggested to be associated with chronic hyperammonemia. Replacement of threonine with asparagine decreases the activity of carbamoyl phosphate synthase in the urea cycle. Genetic screening can potentially identify a population at risk before initiation of antiepileptic therapy.

PMID:
21821508
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk